Rock Point Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-25,340
Closed -$2.18M 95
2022
Q4
$2.18M Sell
25,340
-21,764
-46% -$1.87M 0.75% 42
2022
Q3
$2.91M Sell
47,104
-490
-1% -$30.2K 1.08% 34
2022
Q2
$2.94M Sell
47,594
-34,961
-42% -$2.16M 1% 39
2022
Q1
$4.91M Buy
82,555
+200
+0.2% +$11.9K 1.46% 32
2021
Q4
$5.98M Buy
82,355
+27,826
+51% +$2.02M 1.68% 25
2021
Q3
$3.81M Sell
54,529
-235
-0.4% -$16.4K 1.12% 41
2021
Q2
$3.77M Buy
54,764
+1,035
+2% +$71.3K 1.09% 36
2021
Q1
$3.47M Buy
53,729
+1,154
+2% +$74.6K 1.08% 35
2020
Q4
$3.06M Buy
52,575
+21,537
+69% +$1.25M 1.05% 34
2020
Q3
$1.96M Buy
31,038
+2,367
+8% +$150K 0.87% 37
2020
Q2
$2.21M Sell
28,671
-28,741
-50% -$2.21M 1.03% 35
2020
Q1
$4.29M Sell
57,412
-82,340
-59% -$6.16M 2.54% 15
2019
Q4
$9.08M Buy
139,752
+2,515
+2% +$163K 3.69% 10
2019
Q3
$8.7M Buy
137,237
+4,359
+3% +$276K 3.93% 9
2019
Q2
$8.98M Buy
132,878
+799
+0.6% +$54K 4.08% 8
2019
Q1
$8.59M Buy
132,079
+8
+0% +$520 4.04% 9
2018
Q4
$8.26M Sell
132,071
-7,207
-5% -$451K 4.24% 7
2018
Q3
$10.8M Sell
139,278
-415
-0.3% -$32K 4.79% 4
2018
Q2
$9.9M Buy
139,693
+25,783
+23% +$1.83M 4.66% 6
2018
Q1
$8.59M Sell
113,910
-3,180
-3% -$240K 4.23% 7
2017
Q4
$8.39M Buy
117,090
+794
+0.7% +$56.9K 3.91% 9
2017
Q3
$9.42M Sell
116,296
-7,481
-6% -$606K 4.39% 4
2017
Q2
$8.76M Buy
123,777
+3,472
+3% +$246K 4.12% 4
2017
Q1
$8.17M Buy
120,305
+26,657
+28% +$1.81M 4.16% 8
2016
Q4
$6.71M Buy
93,648
+46,088
+97% +$3.3M 3.45% 10
2016
Q3
$3.76M Buy
47,560
+21,535
+83% +$1.7M 1.97% 19
2016
Q2
$2.17M Buy
+26,025
New +$2.17M 1.16% 33